Rating History for Cyclacel Pharmaceuticals (CYCC) by Roth/MKM

More Stocks Rated by Roth/MKM | Latest Ratings for CYCC
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/23/2024 Jonathan Aschoff Downgrade Neutral
(Buy)		 1.00
(11.00)		 1.43
(6.37)		 345.45% Details